PHOSPHORIC ACID


Synonyms	Acidum phosphoricum Amberphos 54 E 338 E-338 E338 FEMA NO. 2900 INS NO.338 INS-338 NSC-80804 Phosphoric Acid Phosphoric acid Phosphoricum acidum Vococid Wc-reiniger Y-11A06
Status
Molecule Category	Free-form
UNII	E4GA8884NN
EPA CompTox	DTXSID5024263


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70

Structure


InChI Key	NBIIXXVUZAFLBC-UHFFFAOYSA-N
Smiles	O=P(O)(O)O
InChI	InChI=1S/H3O4P/c1-5(2,3)4/h(H3,1,2,3,4)

Physicochemical Descriptors

Property Name	Value
Molecular Formula	H3O4P
Molecular Weight	97.99
AlogP	-0.93
Hydrogen Bond Acceptor	1.0
Hydrogen Bond Donor	3.0
Number of Rotational Bond	0.0
Polar Surface Area	77.76
Molecular species	ACID
Aromatic Rings	0.0
Heavy Atoms	5.0

Cross References

Resources	Reference
ChEBI	26078
ChEMBL	CHEMBL1187
DrugBank	DB09394
DrugCentral	4478
FDA SRS	E4GA8884NN
Human Metabolome Database	HMDB0002105
KEGG	C00009
PubChem	1004
SureChEMBL	SCHEMBL22

CONTENTS


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).